
Efficacy and safety of TMC278 in treatment‐naïve, HIV‐1‐infected patients with HBV/HCV co‐infection enrolled in the phase III ECHO and THRIVE trials
Author(s) -
Nelson M,
Amaya G,
Clumeck N,
Arns Da Cunha C,
Jayaweera D,
Junod P,
Taisheng L,
Tebas P,
Stevens M,
Buelens A,
Vanveggel S,
Boven K
Publication year - 2010
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.1186/1758-2652-13-s4-p210
Subject(s) - medicine , human immunodeficiency virus (hiv) , virology
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK